We are live on ! Find out more
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

1 hedge funds and large institutions have $896K invested in Portfolio Building Block World Pharma and Biotech Index ETF in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.13% more ownership

Funds ownership: 0% → 0.13% (+0.13%)

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$887K

Top Sellers

No sellers this quarter

PBPH Hedge Fund Activity: Q4 2025 in Review

1 of the 8,281 institutional investors tracked by Wall St. Rank reported a position in Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) for Q4 2025, worth a combined $896K.

Buyers outnumbered sellers: 1 fund opened new PBPH positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $887K.

  • 1 institutional investor held Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) as of Q4 2025, up from 0 in Q3 2025.
  • Funds reported $896K of Portfolio Building Block World Pharma and Biotech Index ETF stock for Q4 2025.
  • 1 fund opened new Portfolio Building Block World Pharma and Biotech Index ETF positions in Q4 2025 and 0 closed out, a net change of +1 holder.
  • The largest Portfolio Building Block World Pharma and Biotech Index ETF buyer in Q4 2025 was Citadel Advisors, an estimated $887K added.

Based on aggregated 13F filings for Q4 2025.